Beumers, L., Vlachavas, E., Borgoni, S., Schwarzmüller, L., Penso-Dolfin, L., Michels, B. E., . . . Wiemann, S. (2023). Clonal heterogeneity in ER+ breast cancer reveals the proteasome and PKC as potential therapeutic targets. npj Breast cancer, 9(1), . https://doi.org/10.1038/s41523-023-00604-4
Chicago-Zitierstil (17. Ausg.)Beumers, Lukas, et al. "Clonal Heterogeneity in ER+ Breast Cancer Reveals the Proteasome and PKC as Potential Therapeutic Targets." Npj Breast Cancer 9, no. 1 (2023). https://doi.org/10.1038/s41523-023-00604-4.
MLA-Zitierstil (9. Ausg.)Beumers, Lukas, et al. "Clonal Heterogeneity in ER+ Breast Cancer Reveals the Proteasome and PKC as Potential Therapeutic Targets." Npj Breast Cancer, vol. 9, no. 1, 2023, https://doi.org/10.1038/s41523-023-00604-4.